-
Founded in:
2001-05-30 -
Country:
China -
Address:
No. 8 Road, Chengbei Industrial Park, Zhangshu City, Jiangxi Province -
Tax NO.:
91360900716598386X -
Registered Funds:
6.23540698 yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Chondroitin 4-sulfate |
1. Remove lipids and lipoproteins from the blood, remove cholesterol from the blood vessels around the heart, prevent and treat atherosclerosis, and increase the conversion rate of lipids and fatty acids in cells; 2. Prevent and treat coronary heart disease, resist atherosclerosis and the formation of atherosclerotic plaques, increase coronary artery branches or collateral circulation, and accelerate the healing, regeneration and repair of myocardial necrosis or degeneration; 3. Increase the biosynthesis of cellular mRNA and DNA, and promote cell metabolism; 4. Has a mild anticoagulant effect (each 1 mg of chondroitin sulfate A is equivalent to the anticoagulant activity of 0.45U heparin); 5. Has anti-inflammatory, accelerated wound healing and anti-tumor effects.
More
1. Remove lipids and lipoproteins from the blood, remove cholesterol from the blood vessels around the heart, prevent and treat atherosclerosis, and increase the conversion rate of lipids and fatty acids in cells; 2. Prevent and treat coronary heart disease, resist atherosclerosis and the formation of atherosclerotic plaques, increase coronary artery branches or collateral circulation, and accelerate the healing, regeneration and repair of myocardial necrosis or degeneration; 3. Increase the biosynthesis of cellular mRNA and DNA, and promote cell metabolism; 4. Has a mild anticoagulant effect (each 1 mg of chondroitin sulfate A is equivalent to the anticoagulant activity of 0.45U heparin); 5. Has anti-inflammatory, accelerated wound healing and anti-tumor effects. |
24.0%Chondroitin sulfate labeled amount | 9007-28-7 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cephalexin |
By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls, inhibits or kills bacteria; when used with trimethoprim, it improves antibacterial ability, delays the development of drug resistance, and reduces oral doses
More
By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls, inhibits or kills bacteria; when used with trimethoprim, it improves antibacterial ability, delays the development of drug resistance, and reduces oral doses |
125mg | 15686-71-2 | 33 |
| Trimethoprim |
By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls, inhibits or kills bacteria; when used with cephalexin, it can improve antibacterial ability, delay the development of drug resistance, and reduce oral dosage
More
By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls, inhibits or kills bacteria; when used with cephalexin, it can improve antibacterial ability, delay the development of drug resistance, and reduce oral dosage |
25mg | 738-70-5 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Atificial Cow-bezoar |
|
1002-00-2 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Berberine hydrochloride |
Effective for intestinal infections caused by Shigella dysenteriae and Escherichia coli
More
Effective for intestinal infections caused by Shigella dysenteriae and Escherichia coli |
0.1g | 633-65-8 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Norfloxacin |
This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.
More
This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death. |
70458-96-7 | 35 |